FDA Drug Application (020234) for TEGRETOL-XR by NOVARTIS

Back to FDA Applications sponsored by NOVARTIS

Application Number020234
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage100MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameTEGRETOL-XR
Active IngredientCARBAMAZEPINE

Active IngredientCount
List of drugs with Active Ingredient CARBAMAZEPINE8


Back to FDA Applications sponsored by NOVARTIS